MATERIAL TRANSFER AND CONFIDENTIALITY AGREEMENTMaterial Transfer and Confidentiality Agreement • May 22nd, 2014 • Vascular Biogenics Ltd. • Pharmaceutical preparations
Crucell Holland B.V., a dutch Company with offices located at Archimedesweg 4, 2333 CN, Leiden, the Netherlands, hereinafter referred to as “CRUCELL”; and
CLINICAL TRIAL AGREEMENT Protocol No. VB-201-079 EudraCT No. 2012-002763-10Clinical Trial Agreement • May 22nd, 2014 • Vascular Biogenics Ltd. • Pharmaceutical preparations
This means any untoward medical occurrence in a patient or clinical trial subject administered with a medicinal product and which does not necessarily have a causal relationship with the Project.
CRUCELL HOLLAND B.V. – VASCULAR BIOGENICS LTD. COMMERCIAL GENE THERAPY LICENSE AGREEMENTCommercial Gene Therapy License Agreement • May 22nd, 2014 • Vascular Biogenics Ltd. • Pharmaceutical preparations
This Commercial Gene Therapy License Agreement (“Agreement”) is made and entered into on April 15, 2011 (“EFFECTIVE DATE”) by and between:
